• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • New Details on Sampling Inspections of Medical Devices

New Details on Sampling Inspections of Medical Devices

Friday, 23 April 2021 / Published in Medical Device, News, NMPA Registration in China

New Details on Sampling Inspections of Medical Devices

On April 12, the NMPA (National Medical Products Administration) announced (No.45-2021) the inspection plan for medical devices. For foreign manufacturers, this is most relevant for post-market activities and will be useful when manufacturers are notified for sampling inspections by the NMPA.

Highlights

  • The inspection work shall be carried out in accordance with the mandatory standards or product technical requirements as indicated in the item list (attached in the NMPA announcement).
  • If the medical device manufacturer objects to the inspection results, he can apply for re-inspection within 7 working days from the date of receiving the results. The medical device manufacturer should refer to the list of inspection companies (attached in the NMPA announcement) to apply for re-inspection.
  • If the medical device manufacturer objects the test method and test basis and at the same time fails the re-inspection, he can apply for an appeal with the respective MPA within 10 working days from the date of receiving the results. Upon receiving the application, the MPA will investigate and submit a proposal report to the NIFDC (National Institutes for Food and Drug Control).

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Sampling Inspection

What you can read next

Clinical Trials GMP management
Clinical Trials GMP Management Specification for Drugs – Appendix (Draft) Issued
Clinical Trial Guidelines Updated & Various Draft Product Guidelines Issued
Draft of TSG 22 for mobile pressure vessels published for comments

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...
  • China medical device quality safety responsibility

    China medical device quality and safety responsibility regulations come into force on March 1, 2023

    China medical device quality and safety respons...
  • China drug standards draft measures

    China drug standards draft measures have been published by the NMPA

    China drug standards draft measures have recent...
  • China special equipment safety supervision

    China special equipment safety supervision – draft provisions released

    China special equipment safety supervision regu...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.